Navigation Links
Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
Date:11/6/2013

SAN DIEGO, Nov. 6, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that it has entered into a commercial supply agreement with Sanofi to act as Orexigen's contract manufacturer for Contrave® (32 mg naltrexone sustained release (SR) / 360 mg bupropion SR) for territories outside North America.  Sanofi will manufacture Contrave tablets at one of several facilities in France.

"We are pleased to engage a manufacturer with Sanofi's scale and expertise," said Michael Narachi, CEO of Orexigen. "This agreement expands and diversifies our existing commercial supply network and will help ensure we will be ready to supply Contrave globally if approved."

About Contrave
Orexigen is evaluating Contrave for the management of obesity, including weight loss and maintenance of weight loss, in conjunction with lifestyle modification, and is currently conducting the Light Study, a cardiovascular outcomes trial. The primary objective of the double‐blind, randomized, placebo‐controlled clinical trial, which Orexigen is conducting under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA), is to rule out excess cardiovascular risk in overweight and obese patients receiving Contrave. An interim analysis of the Light Study is anticipated by early December, enabling the potential resubmission of the Contrave New Drug Application (NDA) to the FDA by year end.

In October Orexigen submitted a Marketing Authorization Application (MAA) for Contrave to the European Medicines Agency (EMA).

Orexigen has licensed North American Contrave commercial rights to Takeda Pharmaceuticals. Orexigen owns Contrave rights in Europe and
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
2. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
3. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
4. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
5. Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
6. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
7. Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
8. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
9. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
10. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
11. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Pulse Systems, Inc. , an ... Practice Management , and Revenue Cycle Management (RCM) solutions ... performed by some RCM vendors, at UBM Medica,s Practice ... on September 19-20, 2014.  A presenter at ... September with a new session encouraging practices to "Look before ...
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... Reportlinker.com announces that a new market research ... Food Eastern Europe 2014 http://www.reportlinker.com/p02312454/Baby-Food-Eastern-Europe-2014.html ... is a new report by ERC that analyzes the ... Europe , key segments, features & developments, future ... trends which are currently affecting the industry. Furthermore, it ...
Breaking Medicine Technology:Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8
... 2011 Four hospitals serving Virginia patients reduced healthcare-acquired ... days, resulting in savings of $1.2 million in additional ... persistent action plan to existing federal hand washing protocols, ... fewer infections and reduced patient length-of-stay and unnecessary readmissions. ...
... Pharmaceuticals, Inc., a publicly held corporation, (Symbol: PDRX.PK) ... an electronic medical record, from Wilson Medical Software, ... quality, low-cost tool for physicians to maintain patient ... and assistants to rapidly record visit notes and ...
Cached Medicine Technology:Virginia Hospitals Reduce Infections 41% 2Virginia Hospitals Reduce Infections 41% 3PD-Rx Pharmaceuticals Acquires Wilson Medical's EMR 2
(Date:8/27/2014)... Jaha was founded with a vision that fitness is ... industry’s most affordable fitness tracker together with an app to ... Jaha plans to announce their latest concept, an ... locate, challenge and motivate. , The Jaha Kickstarter ... support and to raise awareness on this new concept for ...
(Date:8/27/2014)... Representatives with Recharge Retreats announced ... of destinations for International Yoga Teacher Trainings. , Chris ... the company chose Italy due to the fact that ... since it's an easy flight for Canadians and Americans, ... all over Europe, UK, Africa, and the Middle East. ...
(Date:8/27/2014)... 27, 2014 Cash House 's contributions ... the overall upkeep of the shelter including new initiatives and ... to change the lives of each youth who walk through ... emergency shelter for youth ages 16-25. Not only does Horizons ... and resources for the youth who come through their doors. ...
(Date:8/27/2014)... 2014 Nava Beauty Store and Spa aims ... patrons from those seeking luxury care products to the everyday ... high end luxurious brands like Valmont and Elemis to cater ... brands like Dermalogica and Bliss to provide easy to use ... also offer purely organic skin care products such as Jurlique, ...
(Date:8/27/2014)... August 27, 2014 The Global and ... study on the current state of the Maleic Anhydride ... a basic overview of the industry, including definitions, applications ... domestic market analysis are provided with a focus on ... A comparison between the international and Chinese situation is ...
Breaking Medicine News(10 mins):Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3Health News:Cash House a Major Supporter of Horizons for Youth 2Health News:Cash House a Major Supporter of Horizons for Youth 3Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 4Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 5
... Ltd today said it has commenced commercial production at its ... Stock Exchange that the finished dosage pharmacuetical formulations unit would ... and the project is being implemented in stages., ,Plans ... it added., ,The share of the company was trading ...
... the conference held at Varca in Goa it is ... high homocysteine levels. //The two day conference mainly ... practices lead to hyperhomocysteinemia. This would further worsen the ... as strokes, heart attack, diabetes and other fatal diseases. ...
... revealed compounds, which stimulate growth hormone production help older ... of a study published at the International Congress of ... work in adults to improve their physical function and ... will be presented by Dr. George Merriam, professor of ...
... successfully completed with 96 percent of children under five being ... Days (NIDs). // ,Carried out on April ... cover 22 million children under the age of five, to ... ,The campaign was triggered by the affirmation ...
... claimed to have performed the world's first triple-transplant operation ... , said a report Monday. ,Surgeons at Sydney's ... Leanne Myles of Cowra in central-eastern New South Wales, ... ,Leanne, 33, was suffering from an auto-immune disease. ...
... on the verge of another outsourcing wave: high-end laboratory and ... over 1,500 tests under one roof. // , ... outsourcing laboratory and diagnostic tests to India as it costs ... here. At the moment, this is generally limited to highly-specialised ...
Cached Medicine News:Health News:Growth Hormone Stimulants help to Combat Aging Symptoms 2Health News:Growth Hormone Stimulants help to Combat Aging Symptoms 3
Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
Sealing Mat for 96-well PCR Plate, Natural...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: